Managing Epilepsy and Seizures in Aicardi Syndrome
At a Glance
Aicardi syndrome epilepsy often begins in infancy and may be difficult to control. Treatment focuses on reducing seizure frequency and severity, preventing injuries, and improving quality of life through medicines, a supervised ketogenic diet, VNS, or selected surgery.
Managing epilepsy is often the most significant challenge for families living with Aicardi syndrome. Because the condition involves widespread changes in how the brain is formed, the seizures that result are typically complex and difficult to control with medication alone [1][2]. While achieving total “seizure freedom” is uncommon in Aicardi syndrome, the goal of treatment is often focused on seizure-reduction and symptom-directed treatment—meaning the focus is on reducing the number and severity of seizures, preventing injuries, and improving your child’s quality of life [3][4].
The Typical Seizure Journey
For most children with Aicardi syndrome, epilepsy begins very early, often within the first few months of life. The median age for the first seizure is approximately 2.2 months [5].
- Infantile Spasms: The first sign is usually infantile spasms (or epileptic spasms). These are sudden, brief stiffening of the body, arms, or legs that often occur in “clusters” when the child is waking up or falling asleep [6]. Suspected infantile spasms are time-sensitive and require prompt pediatric epilepsy assessment and video-EEG confirmation. Do not wait for a routine visit if you suspect these spasms. Evidence-based first-line approaches commonly include hormonal treatment (such as ACTH or prednisolone) and/or vigabatrin, depending on the clinical situation. Early treatment matters.
- Evolution to Drug Resistance: Over time, these spasms often evolve into other seizure types, such as tonic seizures (sudden stiffening) or “drop attacks” [4].
- Refractory Epilepsy: Most children (over 90%) develop refractory epilepsy, also known as drug-resistant epilepsy. This means the seizures continue even after trying two or more appropriately chosen and dosed antiseizure medications [2][4].
The Ketogenic Diet
When medications do not provide enough relief, many families turn to the ketogenic diet. This is a medical, high-fat, low-carbohydrate diet that changes how the brain uses energy. It must be managed strictly by a specialized medical team, including a neurologist and a dietitian. It carries serious safety considerations, including screening for contraindications, medication-carbohydrate issues, hypoglycemia, dehydration, acidosis, kidney stones, and nutrient deficiencies.
Research specifically looking at children with Aicardi syndrome found encouraging, though preliminary, results for the ketogenic diet:
- Response Rate: In a small study of 15 patients, 67% (10 out of 15) achieved at least a 50% reduction in their seizures after three months on the diet [3]. Because this study was small, this percentage should not be viewed as an exact predicted success rate for every individual child.
- High Success: About 20% of those children saw a 90% or greater reduction in seizures [3].
- Reality Check: While the diet can significantly lower the number of seizures, it rarely stops them entirely. In the same study, only one child achieved temporary seizure freedom [3]. Families must not attempt the diet without a specialized epilepsy-nutrition program.
Surgical and Adjunctive Options
If the ketogenic diet and medications are not enough, your medical team may discuss surgical interventions. These are typically viewed as options requiring comprehensive epilepsy-center evaluation to reduce the seizure burden rather than a “cure” for epilepsy.
Vagus Nerve Stimulation (VNS)
A Vagus Nerve Stimulator (VNS) is a small device surgically implanted under the skin of the chest. A wire travels from the device to the vagus nerve in the neck, sending regular, mild pulses of electricity to the brain to help calm seizure activity [7]. While data specific to Aicardi syndrome is limited, VNS is a common adjunctive option for children with drug-resistant epilepsy to help reduce seizure frequency and shorten recovery time after a seizure [7].
Corpus Callosotomy
A corpus callosotomy is a procedure where the connection between the two halves of the brain is severed. In Aicardi syndrome, where the corpus callosum is already partially or completely missing, this surgery is only considered in highly specific, individualized cases [4].
- Goal: The main goal is to stop seizures from spreading from one side of the brain to the other, which can prevent sudden “drop attacks” that cause falls and injuries [8].
- Candidacy: This is most often discussed for children who have a partially formed corpus callosum and suffer from frequent, disabling falls [4]. A person with complete agenesis has no normal corpus callosum to sever.
Measuring Success
In Aicardi syndrome, success is often measured by more than just a “seizure count.” Families and doctors look at whether a treatment helps the child be more alert, improves their ability to participate in therapies, or reduces the need for emergency room visits. Because the burden of malformations in the brain is high, the management of epilepsy is a lifelong process that requires frequent adjustments and a dedicated care team [1][9].
Common questions in this guide
When do seizures usually begin in Aicardi syndrome?
What does drug-resistant epilepsy mean for a child with Aicardi syndrome?
Can a ketogenic diet reduce seizures in Aicardi syndrome?
What is VNS, and could it help with Aicardi syndrome epilepsy?
Could corpus callosotomy help prevent drop attacks?
How do doctors measure whether epilepsy treatment is helping?
How can we prepare for seizure clusters or prolonged seizures?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given that my child's seizures have not responded to several medications, is it time to consider a referral to a level 4 pediatric epilepsy center?
- 2.Based on the small study's responder rate, is my child a good candidate for the ketogenic diet, and what are the specific safety risks we would need to monitor?
- 3.Does my child's brain structure, specifically the degree of corpus callosum formation, make them a candidate for a corpus callosotomy?
- 4.What are the specific risks and expected benefits of Vagus Nerve Stimulation (VNS) for a child with Aicardi syndrome?
- 5.Can we develop a formal 'Seizure Action Plan' for seizure clusters or prolonged events that specifies when to use emergency medication?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Agenesis of the Corpus Callosum and Aicardi Syndrome: A Neuroimaging and Clinical Comparison.
Govil-Dalela T, Kumar A, Agarwal R, Chugani HT
Pediatric neurology 2017; (68()):44-48.e2 doi:10.1016/j.pediatrneurol.2016.12.002.
PMID: 28214165 - 2
Basal Ganglia Dysmorphism in Patients With Aicardi Syndrome.
Masnada S, Pichiecchio A, Formica M, et al.
Neurology 2021; (96(9)):e1319-e1333 doi:10.1212/WNL.0000000000011237.
PMID: 33277420 - 3
Ketogenic Diet Therapy for Epilepsy Associated With Aicardi Syndrome.
Sanchez MAR, Cervenka MC, Bessone SK, Kossoff EH
Journal of child neurology 2021; (36(11)):1007-1010 doi:10.1177/08830738211023335.
PMID: 34240629 - 4
Corpus Callosotomy for Refractory Epilepsy in Aicardi Syndrome: Case Report and Focused Review of the Literature.
Bernstock JD, Olsen HE, Segar D, et al.
World neurosurgery 2020; (142()):450-455 doi:10.1016/j.wneu.2020.06.230.
PMID: 32652281 - 5
Systematic quantitative modeling of the natural history of Aicardi syndrome: A cross sectional study of 245 published cases.
Urban OY, Driedger JH, Garbade SF, et al.
Orphanet journal of rare diseases 2024; (19(1)):457 doi:10.1186/s13023-024-03375-8.
PMID: 39633384 - 6
Microphthalmia and Infantile Spasms Leading to the Diagnosis of Aicardi Syndrome: A Case Report and Literature Review of a Rare Entity.
Amanallah MR, Chraa M, Louhab N, Balili K
Cureus 2025; (17(12)):e99822 doi:10.7759/cureus.99822.
PMID: 41573467 - 7
The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis.
Hajtovic S, LoPresti MA, Zhang L, et al.
Journal of neurosurgery. Pediatrics 2022; (29(6)):667-680 doi:10.3171/2022.1.PEDS222.
PMID: 35303699 - 8
Rates and predictors of seizure outcome after corpus callosotomy for drug-resistant epilepsy: a meta-analysis.
Chan AY, Rolston JD, Lee B, et al.
Journal of neurosurgery 2019; (130(4)):1193-1202 doi:10.3171/2017.12.JNS172331.
PMID: 29999448 - 9
Aicardi syndrome and cognitive abilities: A report of five cases.
Tuft M, Østby Y, Nakken KO, Lund C
Epilepsy & behavior : E&B 2017; (73()):161-165 doi:10.1016/j.yebeh.2017.05.002.
PMID: 28641168
This page explains epilepsy management options in Aicardi syndrome for informational purposes only and does not constitute medical advice. Your child’s pediatric neurologist or epilepsy team should guide urgent evaluation, medicines, dietary therapy, and surgical decisions.
Get notified when new evidence is published on Aicardi syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.